Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
PCORnet Opioid Surveillance Study
NCT03743493 · View on ClinicalTrials.gov ↗
Study Summary
The overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for opioid surveillance to complement existing and support future initiatives. This project will characterize risk factors, processes, and outcomes related to opioid use, misuse, and abuse. It will quantify the utility of data stored in the PCORnet Common Data Model format stewarded by healthcare organizations participating in PCORnet.
Conditions Studied
Study Locations (20)
California
- University of California - Irvine — Irvine
- University of California - San Diego — La Jolla
- University of Southern California — Los Angeles
- Cedars-Sinai Medical Center — Los Angeles
- University of California - Los Angeles — Los Angeles
- Patient-Centered SCAlable National Network for Effectiveness Research — San Diego
- University of California - San Francisco — San Francisco
- San Mateo Medical Center — San Mateo
Pennsylvania
- Penn State College of Medicine — Hershey
- Temple University — Philadelphia
- University of Pittsburgh Medical Center — Pittsburgh
Louisiana
- Research Action for Heath Network — New Orleans
- University Medical Center — New Orleans
New York
- New York City Clinical Data Research Network — New York
- Weill Cornell Medicine — New York
Oregon
- ADVANCE Clinical Data Research Network — Portland
- OCHIN, Inc — Portland
Florida
- Health Choice Network — Miami
Maryland
- Johns Hopkins University — Baltimore
Massachusetts
- Fenway Health — Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,438,284 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2019-11-15 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03743493
The ClinicalTrials.gov registry entry for NCT03743493 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 15,438,284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana Public Health Institute, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03743493 reports 20 study locations spanning 8 distinct geographic areas — top geographies include California, Pennsylvania, Louisiana. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03743493 about?
NCT03743493 is a clinical study titled "PCORnet Opioid Surveillance Study". The overarching objective of this project is to demonstrate and assess the feasibility of using the Patient Centered Outcomes Research Network (PCORnet) Common Data Model for opioid surveillance to complement existing and support future initiatives. This project will characterize risk factors, proce...
What is the current status of trial NCT03743493?
This trial is currently completed. The enrollment target is 15,438,284 participants. The study started on 2018-07-01. Estimated completion is 2019-11-15.
What conditions does trial NCT03743493 study?
This clinical trial studies the following conditions: Opioid Use, Opioid Abuse. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT03743493?
This trial is sponsored by Louisiana Public Health Institute, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03743493 being conducted?
This trial has 20 study locations across California, Florida, Louisiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.